marrow became totally aplastic, and heroic but unsuccessful efforts were made to keep this young woman alive in the hope that marrow regeneration would occur. If a working chart had been kept as part of the discipline of management, the dangerous trends of the platelet and neutrophil counts would have been apparent at an early stage, and the drug might have been discontinued in time. A useful precaution, which, if observed, would almost certainly have saved another life lost as a result of overdosage, is to prescribe only sufficient tablets to last until the next appointment.
Busulphan is still the treatment of choice for chronic granulocytic leukemia, and I recently saw a patient of Dr L G Israels's in Winnipeg who had taken busulphan continuously for thirteen years and whose remission was still maintained. However, a small minority of patients develop a curious wasting syndrome with some features ofAddison's disease after prolonged busulphan therapy (Kyle et al. 1961) . Some of these patients also develop dyspnoea, cough, and low grade fever which progress and may lead to extreme respiratory distress , Koss et al. 1965 , Smalley & Wall 1966 . This is due to alveolar capillary block caused by exudation of fibrin into the alveoli with subsequent organization. It is possible that some of these patients might improve if the condition were detected earlier and busulphan replaced by some other drug such as mercaptopurine or demecolcine (Colcemid). But one of my patients developed the Addison-like syndrome and pulmonary failure four months after the cessation of busulphan therapy which he had had for the previous two years. Fortunately these complications are excessively rare and should not contraindicate busulphan therapy.
Lymphosarcoma Complicated by Serous Effusions
Generalized lymphosarcoma complicated by massive serous effusions often involves both pleural cavities as well as the peritoneal cavity. Usually this situation is associated with a very different type of disease from that discussed above in connexion with mediastinal lymphosarcoma. Here the pathology is that of well-differentiated lymphocytic lymphoma, more often follicular than diffuse. It is usually associated with massive generalized lymph-node enlargement, sometimes with hepatosplenomegaly, and with gross aedema. Here the most effective treatment is probably prednisone or its equivalent, at a daily oral dose of 40 mg. This induces a rapid diuresis with resorption of the effusions, and subsidence of the cedema. The effect is probably due to the rapid shrinkage of the enlarged lymph nodes and release of the blocked lymphatic drainage. Even chylous effusions may respond. Intracavitary injections of nitrogen mustard, other alkylating agents, or radioactive gold are likely to be ineffective. The steroid therapy should be replaced after six or eight weeks by an alkylating agent such as chlorambucil or cyclophosphamide, the administration of which may have to be continued indefinitely to prevent relapse. It is essential here, as in all other types of case to which I have referred, to maintain continuity of follow up and adequate suppressive therapy. One of these patients who had been grossly cedematous for many months and was quite incapacitated had been successfully treated with prednisone and chlorambucil, but was lost to follow-up for two and a half years. She had received no further therapy, had relapsed shortly afterwards, and once more became bedridden. She has again responded to treatment, but it is depressing that more than two years of her life have been wasted. Part of the blame in this case is due to the still too prevalent pessimism associated with malignant disease. Patients with malignant disease are expected to relapse, and all too often when they do so little or no effort is made to discover what might be done for them.
Mr G Westbury (Westminster Hospital, London)

Intra-arterial Administration of Cytotoxic Drugs
The treatment of localized malignant disease by cytotoxic agents administered into the appropriate artery was first reported -in 1950 (Klopp et al.) . Nitrogen mustard (HN2) was given by intermittent injection into the carotid arteries of a group of patients with tumours of the head and neck. Lesions such as carcinoma of the mouth, ordinarily untreatable by chemotherapy, responded dramatically to doses of a conventional order but delivered in a very high local concentra-tion. Unfortunately systemic toxic effects were produced by the nitrogen mustard returning through the veins of the treated region. The ideal agent for regional chemotherapy would be completely utilized in its passage through the capillary bed or broken down en route in the draining veins. Such a drug was not then available and two methods were evolved to reduce the danger of 'spillover' into the general circulation so as to enhance even further the advantage of increased local concentration. The first modification, reported in 1958 (Creech et al.), was the vascular isolation of the region whose circulation containing the cytotoxic agent was maintained by a pump oxygenator. The second modification published in the following year was to neutralize the 'spillover' by an antagonist to the drug given systemically in a dose insufficient to block the high regional concentration (Sullivan et al. 1959 ).
Extracorporeal Perfusion (Irvine 1963) This elaborate technique was initially applied to various types of cancer but for practical purposes is now confined to the treatment of malignant melanoma of the limbs. (Westbury 1963) Simple intra-arterial administration of cytotoxic drugs, whether by repeated injection ofcontinuous infusion is usually conducted via a fine indwelling plastic catheter. The catheter is introduced either by surgical exposure of the artery or, where more appropriate, by percutaneous puncture. The motive power for infusion may be gravity, using a sufficiently high drip set, or more conveniently some form of pump. Infusion may continue for weeks or months, and the use of small portable clockwork pumps for outpatient use has been reported (Sullivan & Zurek 1964) . Accurate localization of the catheter tip is essential and is usually best obtained by injecting coloured dyes, though occasionally arteriography is necessary. Such injections show that the area treated is sharply defined by the blood supply, e.g. mid-line lesions require bilateral treatment. The question of blood supply is also important in organs which have a dual circulation, such as the liver and the lung; liver tumours, for example, whether primary or secondary, are vascularized by the hepatic artery and not by the portal vein.
Intra-arterial Injection and Infusion
Of the many cytotoxic drugs we have so far tested, 2-ethylhydrazide of podophyllic acid (SPI Sandoz) is of special note because it is the one agent which can be pushed to the limit of tissue tolerance without depressing the white cell count (Newton et al. 1964 ). This points the way towards simplicity of technique and foreshadows the obsolescence of complex apparatus such as is required for extracorporeal perfusion.
Discussion
Widespread early enthusiasm for these methods of therapy has waned as their advantages and shortcomings have been appreciated.
Intra-arterial cannulation, especially if prolonged, may be complicated by thrombosis, embolism, septicLemia or secondary hmmorrhage. Extravasation of an irritant cytotoxic drug may produce local tissue necrosis. Regional toxic effects include blistering and cedema of skin and subcutaneous tissues, and peripheral nerve damage; systemic toxicity may follow excessive spillover.
While impressive degrees of tumour shrinkage are frequently observed, complete and prolonged remission is exceptional. This may be explained by the poor blood supply of the central zone of all but the smallest tumours, so that adequate entry of the drug is prevented. The blood supply factor also explains why previously irradiated lesions respond less well than untreated tumoursradiotherapy causes obliterative endarteritis in the treatment field. For this reason regional cytotoxic therapy should precede radiotherapy when combined treatment is proposed.
Conclusions
Experience with almost 600 intra-arterial treatments at Westminster Hospital over the last six years has led to the following conclusions:
(1) The safe conduct of this potentially dangerous form of therapy calls for an expert team of surgeons and radiotherapists and, not least, residents and nurses who will devote meticulous care to the running of the infusion pumps.
(2) Intra-arterial chemotherapy alone is of limited value in the mahagement of localized cancer. It is, rather, an addition to the armamentarium of the team which treats the disease, to be applied with great discrimination and at the correct stage of the therapeutic programme.
